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Abstract
Absinthe, a bitter spirit containing wormwood (Artemisia absinthium L.), was banned at the beginning
of the 20th century as consequence of its supposed unique adverse effects. After nearly century-
long prohibition, absinthe has seen a resurgence after recent de-restriction in many European
countries. This review provides information on the history of absinthe and one of its constituent,
thujone. Medical and toxicological aspects experienced and discovered before the prohibition of
absinthe are discussed in detail, along with their impact on the current situation. The only
consistent conclusion that can be drawn from those 19th century studies about absinthism is that
wormwood oil but not absinthe is a potent agent to cause seizures. Neither can it be concluded
that the beverage itself was epileptogenic nor that the so-called absinthism can exactly be
distinguished as a distinct syndrome from chronic alcoholism.
The theory of a previous gross overestimation of the thujone content of absinthe may have been
verified by a number of independent studies. Based on the current available evidence, thujone
concentrations of both pre-ban and modern absinthes may not have been able to cause detrimental
health effects other than those encountered in common alcoholism. Today, a questionable
tendency of absinthe manufacturers can be ascertained that use the ancient theories of absinthism
as a targeted marketing strategy to bring absinthe into the spheres of a legal drug-of-abuse.
Misleading advertisements of aphrodisiac or psychotropic effects of absinthe try to re-establish
absinthe's former reputation. In distinction from commercially manufactured absinthes with limited
thujone content, a health risk to consumers is the uncontrolled trade of potentially unsafe herbal
products such as absinthe essences that are readily available over the internet.
Introduction
Absinthe – a bitter spirit containing wormwood (Artemisia
absinthium L.) (Figure 1) and other herbs – was one of the
most popular alcoholic beverages of late 19th century
Europe. The emerald green drink was consumed by peo-
ple from all walks of life, including the bohemian upper
class, artists, poets and intellectuals. While the lower
classes celebrated l'heure verte (the green hour) in numer-
ous bars and cafés, painters and poets created famous
paintings and poems dedicated to the "green fairy."
Absinthe was popular in fin-de-siècle Paris and la vie
bohème of Prague. The most remarkable celebrity known
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painter Vincent van Gogh (1853–1890, Figure 2), whose
illness is still a matter of debate among neurologists and
psychiatrists [1-7]. Other famous painters of the time,
such as Henri de Toulouse-Lautrec and Paul Gaugin, and
illustrious poets like Oscar Wilde, Charles Baudelaire, and
Edgar Allan Poe were all fond of absinthe.
Because absinthe consumption reached excessive and
alarming proportions at the turn of the 19th century, many
European governments, as well as the U.S. administra-
tion, successively banned the icon of la vie bohème by sev-
eral prohibition acts. Absinthe was used as an easy target
of the temperance movement with the aim of later pro-
hibiting alcohol in general. But absinthe remained a sin-
gularity as the only kind of alcoholic beverage with a long-
term ban. In some European countries (e.g. UK, Spain,
Czech Republic), however, the "green fairy" survived, but
consumption was comparatively low. The European
Council enacted in 1988 the directive "on the approxima-
tion of the laws of the Member States relating to flavorings
for use in foodstuffs and to source materials for their pro-
duction," that re-allowed wormwood as ingredient of
alcoholic beverages. However, maximum limits of the
wormwood ingredient thujone (Figure 3), which was
speculated to be the most probable cause for absinthism,
were issued [8].
Because of this change of policy, absinthe has seen a
recent resurgence. In contrast to the social, legal and med-
ical problems of the late 19th century, today the image of
the "green fairy" has markedly changed, but still remains
titillating. Today's so called "new absinthe" is offered as a
Vincent van Gogh: Still Life with absinthe (Paris 1887)F gure 2
Vincent van Gogh: Still Life with absinthe (Paris 1887). The 
picture shows one of the countless cafés in Paris, in which 
absinthe was served. Next to the glass filled with absinthe, a 
water bottle is illustrated, which was necessary for drinking 
ritual.
Wormwood, Artemisia absinthium L., drawing of plant, flow-ers, seeds and f uits (drawi g by W. Müller, 1885 repro-duced fr m Thomé [106])Figur  1
Wormwood, Artemisia absinthium L., drawing of plant, flow-
ers, seeds and fruits (drawing by W. Müller, 1885 repro-
duced from Thomé [106]). Wormwood is the characteristic 
aromatic component of absinthe.Page 2 of 14
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claimed properties ranging from spiritual elucidation to
aphrodisiac stimulation – with corresponding pricing. In
parallel, a fan club within the internet community has
emerged. Absinthe can be purchased via the internet from
various countries worldwide, making it possible to receive
it in countries where it is not legally available. Moreover,
numerous recipes for the self-production of absinthe are
available on the internet. To date, it is unclear if the re-
licensing of absinthe will cause similar or even new and
different forensic, medical and social problems as it did in
the late 1800's.
This article provides information on the history of absinthe
and a prime constituent, thujone. Medical and toxicological
aspects experienced and discovered before the prohibition
of absinthe are discussed in detail, along with their impact
on the current situation. It is the intention of the authors to
provide a comprehensive overview of this topic of multi-fac-
eted interest and to discuss this issue objectively.
The rise and fall of wormwood spirits
Documented medical use of wormwood can be dated
back to the Ebers Papyrus, an Egyptian medical document
dating from about 1552 B.C. and the oldest preserved
medical document [9]. This papyrus is believed to be a
copy of the even more ancient books of Thoth (3500
B.C.). The name "wormwood" is derived from its
anthelmintic properties, which were recognized by the
ancient Egyptians.
Wormwood, in the context of its bitter taste, is mentioned
several times in the Old Testament (Jeremiah 9:15,
13:15). In the biblical context, the plant represented a
curse, calamity (Lamentations 3:15) or injustice (Amos
5:7). In Revelations 8:11, the Greek equivalent ho
apsinthos is used as a name for a star that fell into the
waters and turned them bitter. The Greek word apsinthion
– undrinkable – is most probably the ancestor of the word
absinthe. The Greek mathematician and philosopher,
Pythagoras of Samos (569-475 B.C.), recommended
wine-soaked wormwood leaves to alleviate labor pains;
Hippocrates (~460-377 B.C.) used wormwood extracts for
the treatment of menstrual pain and rheumatism [10].
Pliny the Elder (23–79), the Roman scholar and scientist,
also mentioned extracts of wormwood in his opus Historia
Naturalis [11]. In the Middle Ages, wormwood was used as
a purge and vermifuge, and it developed towards a "gen-
eral remedy for all diseases" and was "a herb of Mars" for
its medical powers [10]. Wormwood's bitter taste inspired
women in those days to apply it to their nipples to encour-
age the weaning of their babies. In fact, Shakespeare has
Juliet's nurse expound upon this in Romeo and Juliet.
The image of just a bitter medicine changed to a popular
drink among the masses in the 16th century. The so-called
Purl of Tudor England was a drink composed of hot ale
and wormwood. Dried leaves of wormwood were infused
in proof-spirits, distilled, and sweetened with sugar as pre-
scribed in Smith's Complete Body of Distilling in 1731 [12].
The French physician Pierre Ordinaire is supposedly the
originator of the classic absinthe recipe. Being acquainted
with the ancient use of wormwood, he began to develop a
recipe for an alcoholic drink, which probably contained
wormwood, anise, hyssop, dittany, sweet flag, melissa and
varying amounts of coriander, veronica, chamomile, pars-
ley and (allegedly) spinach. Dr. Ordinaire, who had fled
the French revolution, settled down in Val-de-Travers in
western Switzerland, which has remained an important
centre of absinthe production. In the small town of Cou-
vet, the elixir (68%vol) soon attained the nickname fée
verte.
After Dr. Ordinaire's death, his recipe came into the pos-
session of Henri-Louis Pernod, who began the commer-
cial production of absinthe in 1797. In 1805, Pernod
moved to Pontarlier, France, to serve the French market;
the distillery had one still with a daily capacity of 16 litres.
The widespread use of alcoholic drinks containing worm-
wood extract might have also resulted from the use of
wormwood as a preventive measure for helminthiasis and
fevers during the French conquest of Algeria (1830–
1847). The soldiers returning to France discovered
absinthe as a tasty substitute for their wormwood medi-
cine [13].
Due to a rising interest in anise-based spirits as well as
increased promotion and advertising, the production of
Pernod's absinthe was increased up to a 125,000 liter scale
Structure of α- und β-thujone, the principal components of wormwood oil (Artemisia absinthium L.)Figure 3
Structure of α- und β-thujone, the principal components of 
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tion of red wine in these years due to major damages
caused by the vine pest. The emerald spirit was, however,
known to be enjoyed excessively on both sides of the
Atlantic [14].
The annual per capita consumption of absinthe in France
increased fifteen-fold between 1875 and 1913. According
to an article in The Times (1915), French consumption of
pure alcohol in 1876 was 15,500 hectoliters; it was 10
times that amount in 1908, and in 1913 it had reached the
figure of 239,492 hectoliters, representing 60 liters per
inhabitant [15]. Parallel to this mass consumption and its
consequences, anti-alcohol movements, winegrowers and
clergy called for the banning of absinthe. Many murders
and other acts of violence were attributed to the influence
of absinthe.
Furthermore, the medical community had developed a
strong scientific and medical case against absinthe, attrib-
uting an increase in insanity and other serious medical
problems to an overindulgence in the drink [13]. It was
widely believed that the problem with alcohol was not the
quantity consumed but the quality. The absinthe prohibi-
tion crusade in France was a paradoxical campaign in
which the wine-producers, suppliers of the vast majority
of alcoholic drinks consumed, backed the temperance
movement [16]. The attention being given to absinthe's
supposed unique qualities can be seen as an attempt to
reduce alcoholism without specifically touching alcohol.
However, it also may have diverted efforts away from the
genuine dangers of heavy alcohol consumption [16].
At first, concerns about absinthe were ignored, especially
by the French government, due to lucrative revenues
resulting from the enormous scale of absinthe sales. By
the end of the 19th century, temperance forces had suc-
ceeded in getting the attention of almost all of France
through educational programs and public awareness cam-
paigns. In 1908 a bill was passed that, ironically, increased
the amount of alcohol in absinthe, the argument being
that the requirement for higher alcoholic strength would
eliminate those producers who used artificial essences
with lower standards of purity [13]. Only rising concerns
about a weakening of military power in the light of
absinthe abuse, especially in the army, pressured the
French government to ban absinthe in 1915. The U.S.
Department of Agriculture had already issued the Food
Inspection Decision 147, which banned absinthe in the
U.S., on 25th July 1912. Belgium, Switzerland and Italy
had also passed laws prohibiting absinthe in 1905, 1908
and 1913 respectively; finally, Germany outlawed the
green fairy on 27th April 1923 [17].
Prestwich concluded that the prohibition of absinthe did
little to improve the health of the French people as
deprived of their traditional absinthe consumers merely
switched to similar drinks. In addition, by stressing the
problem of essences and impure alcohol, temperance
campaigners distracted both medical research and the
public from the real cause of alcoholism, namely the
excessive consumption of any type of alcoholic drink [18].
For further information about the social history of
absinthe, which goes beyond the scope of this review, the
book of Adams is recommended [16]. Further informa-
tion is available in the works of Arnold [19,20], Baker
[10], Conrad [21], Lanier [13], Marrus [22], and Prestwich
[18]. Information about absinthes' paraphernalia and the
drinking ritual is available in an article of Hood [23].
Definition of pre-ban absinthe
The drink to which we refer as "pre-ban absinthe" was the
icon of the belle époque. When dealing with good quality
absinthes, recipe books distinguished between absinthe
Suisse, with an alcohol content of approximately 68–72%
vol, absinthe demi-fine, with 50–68% vol and absinthe ordi-
naire, with a content of 45–50% vol. Absinthe suisse was
considered the highest quality and consisted of pure
herbal distillate, while in the other types, the distillate was
diluted with ethyl alcohol. According to these widely
ranging contents, these absinthes must have contained
different concentrations of thujone.
A definition of absinthe was provided in Swiss law at the
time of the prohibition of absinthe. According to this def-
inition, every spirit drink, without regard to its method of
production, that contains aromatic compounds of worm-
wood herb in combination with other aromatic com-
pounds derived from plants such as anise and fennel, is
defined as absinthe [24]. Thujone was regarded as being
the determining factor amongst the aromatic compounds
in terms of detecting wormwood spirits [25].
In the first step of traditional recipes for distilled absinthe,
wormwood and other dried herbs (e.g., anise, fennel) are
macerated. The macerate of the wormwood herb is of
greenish-brown color, smells aromatic, like all Artemisia
species, and reminds one of the composite herbs, like
camomile. The taste is lightly stinging, strongly bitter and
camphoric. The following distillation of the macerate
results in a distillate that is reduced from the bitter com-
pounds, which are relatively non-volatile. The distillation
is conducted in a still with a very flat helmet slowly heated
in a water or steam bath to avoid boilover that would neg-
atively influence the product quality [26,27]. The distilla-
tion process is usually stopped at an alcoholic strength of
60%vol [27,28]. The characteristic, lightly volatile, fine
aromatic components of the wormwood aroma appear inPage 4 of 14
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middle fractions posses a cinnamon or clove-like aroma
[29]. Distillation of absinthe should never be carried on to
the end, as the taste of the product would be too strong,
and less fine [26]. Therefore, only the main fractions
(heart) are used for the production of high-quality
absinthe. The heads and tailings are collected separately
and added to subsequent macerations or used to make
absinthe ordinaire after renewed rectification [28].
As emphasized by Arnold [20], the distillation of absinthe
may have been a type of "steam distillation" as significant
amounts of water were added to the alcoholic macerate
prior to distillation. Due to the influence of steam distilla-
tion, higher thujone may have been distilled over [20].
In the second step, wormwood (usually Artemisia pontica)
and other herbs are added to the colorless distillate. This
is done to accomplish the characteristic green colouring
by chlorophyll and to achieve a mild bitter taste, as well as
to extract other aromatic compounds. Because of the easy
denaturation of chlorophyll through light and warmth,
the characteristic color of a traditionally produced
absinthe is pale greenish-yellow. Afterwards, the beverage
is diluted with water until drinking strength is reached.
Typical historic recipes are given in the books of Duplais
[30], Fritsch [27], Bedel [31] and de Brevans [28]. The
composition of herbs used along with the wormwood dif-
fers from recipe to recipe. To improve the taste or add
coloring, anise, star anise, lemon balm, hyssop, juniper,
nutmeg, veronica, angelica root, melissa, coriander, cam-
omile or parsley were added. Each country produced its
own types of absinthe. For example, in the Czech Repub-
lic, peppermint was added, but neither anise nor fennel.
In Switzerland, melissa, hyssop or angelica root were
added to the Swiss alpine wormwood, which was a valued
ingredient due to its strong aroma [32], while in France,
coriander was added.
Because the essential oils from the diverse herbs can be
kept in solution only in high alcohol concentrations, the
addition of water causes a precipitation visible as an
opaque clouding of absinthe. This phenomenon is called
the Louche effect. The characteristic bitterness is caused by
sesquiterpene-lactone absinthin, which can still be orga-
noleptically detected in a concentration as low as 1 g in
about 70 liters. Due to different historical aspects of
absinthe, a sub-division into the historic "pre-ban
absinthe" and the currently available "modern absinthe"
will be used in this article.
Pre-ban absinthe – a target for food adulteration
Besides the above-mentioned herbal ingredients, different
manufacturers of absinthe sometimes used strange or
even toxic additives such as methanol, sweet flag (Acorus
calamus L.), tansy (Tanacetum vulgare L.), nutmeg (Myris-
tica fragrans HOUT), antimony, aniline green, copper sul-
fate and cupric acetate indigo.
The Lancet reported that, in the days of pre-ban absinthe,
antimony (antimonyl tartrate) was added with the well-
meant intent to decrease absinthe's toxicity. However, it
was questionable even in 1873 if "quantities of tartar
emetic" would not rather adulterate the spirit as it would
cause nausea, sickness and toxic effects of its own [33].
From today's view it is more likely that antimony salts
were added to make absinthe turn milky when adding
water simulating the Louche effect. Increasing consump-
tion, which arose competition among the manufacturers,
flooded the market with such imitations of absinthe.
Absinthe can so easily be adulterated that Emerson won-
dered if the genuine article was still in existence [34].
In addition, instead of traditional production by distilla-
tion, absinthe could be made using herbal essences.
According to Tibbles, the color of properly made absinthe
is entirely due to chlorophyll derived from the green
leaves of wormwood, hyssop, spinach, parsley, nettles and
veronica; however, in the years preceding 1912, the spirit
was most frequently colored by artificial agents [35]. Con-
venience products like absinthe extracts, which had only
to be dissolved in alcohol and colored with food dye [27],
were also commercially available at that time. As food
adulteration, the light green color of chlorophyll was
sometimes enhanced with inorganic salts like copper sul-
phate or copper acetate [36]. Inferior and falsified prod-
ucts were typically made by mixing industrial alcohol
with flavorings and artificial food dyes, in the worst case
with antimony trichloride, and copper salts.
Another general problem at that time was that heads and
tailings, which were separated from the product fractions
during distillation by legal manufacturers, were purchased
by illegal manufacturers and used as a main component
for adulterated absinthe products. The alcohol employed
for absinthe was described to have been "frequently very
impure" [37]. Emerson also wondered if total abolish-
ment had occurred if the beverage had remained in its
purity [34]. Given these facts, it is easily comprehensible
that the prohibition of such a mixture could successfully
eradicate a whole syndrome overnight.
Modern absinthe
Most absinthe brands available today contain mainly the
same herbal ingredients and extracts as pre-ban absinthe.
Absinthe produced within the European Union is limited
in its thujone content to 35 mg/l (maximum limit for bit-
ter spirits) [8].Page 5 of 14
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according to traditional recipes, without the addition of
dye or other additives. Some products are made of herbal
distillates and are differentiated by a mild flavor. Because
such products are colorless, they are sold as Blanche or La
Bleue. Types with a lower alcoholic strength and added
sugar are sold as absinthe-liqueurs. Independent of tradi-
tional recipes, many products sold nowadays are made
with readily bought finished extracts of wormwood or
other plants, which are blended with ethyl alcohol of agri-
cultural origin. For the coloring artificial dye is used, espe-
cially mixtures of tartrazin (E102, FD&C Yellow No. 5)
and patent blue V (E131) or brilliant blue FCF (E133).
Inferior products contain no herbal extracts and are made
solely by the blending of artificial flavors, coloring and
ethyl alcohol [17].
In cases like this, sometimes even the macerated herbs are
not distilled but only filtrated, diluted to drinking
strength and bottled. These products have a strong pro-
nounced taste of wormwood and a very strong, bitter
taste. Further falsification is possible with the addition of
extracts of other thujone-containing plants (e.g., Thuja
occidentalis L., Salvia officinalis L.).
Nineteenth century studies about absinthism
Clincial effects of absinthism
When discussing the clinical effects of thujone and
absinthe, it should be kept in mind that the majority of
the data available was derived from clinical observations
made in the late 1800's and are therefore lacking reliabil-
ity and clinical significance.
With the increasing mass consumption of absinthe, more
and more of the chronic – and most probably high-dose –
absinthe consumers developed seizures, speech impair-
ment, sleep disorder, mental prostration, auditory and
visual hallucinations and finally death. This collection of
symptoms gave birth to the term "absinthism;" it is
unclear, however, if this syndrome ever really existed at
all. Absinthism in these days was supposedly further char-
acterized by brain damage, gastrointestinal problems, risk
of psychiatric disease and even suicide [38]. Even an
increased incidence of oesophageal cancer in absinthe
drinkers was noticed [39]. In contrast, other authors rec-
ommended moderate doses of absinthe as a valuable rem-
edy against depressions [40].
Both the serious and the populist medical literature of the
day demonized absinthe, in many cases laying the
groundwork for the anti-absinthe temperance movement.
The definition of absinthism as a particular syndrome sep-
arate from alcoholism is intimately connected with the
French physician Valentin Magnan. A biography of Mag-
nan is available in a recent review article [41]. In Magnan's
work about absinthism between 1864 and 1874 he
described visual and auditory hallucinations accompa-
nied by alterations in consciousness after consumption of
absinthe [42,43]. Other authors described acute symp-
toms of absinthe, such as hallucination, restlessness, con-
fusion, delirium and seizures [44] (Table 1). Symptomatic
differences between the drinker of absinthe and the ordi-
nary alcoholic were presented at the First International
Eugenics Congress: in absinthism, the "hallucination
insanity" was described to be "more active with sudden
attacks of delirium, more terrifying, sometimes provoking
most dangerous reactions of extreme violence" [45]. In
addition, complete statistics of the central service for the
admission of insane persons for the town of Paris were
given. In the years 1867–1912, a number of 16,532
patients were treated for alcoholic intoxication. 70.3% of
all patients were diagnosed as "chronic alcoholics," but
only 1.0% of all patients were found to have symptoms of
absinthism. Due to the high consumption of absinthe in
Paris of that time, one questions if very severe forms of
chronic alcoholism were misleadingly described as absin-
thism.
In a clinical report on a case of absinthe intoxication, pub-
lished in the Boston Medical and Surgical Journal (today the
New England Journal of Medicine) in 1868, Amory, a former
pupil of Magnan, observed "pleural effusions", "epilepti-
form seizures" and a "reddish discoloration of the urine"
[38]. The latter symptom can be interpreted – among
other possible causes – as an episode of acute porphyria.
It has been shown in vitro that thujone and other terpenes
exhibit porphyrogenic properties. In primary chicken
embryo liver cell cultures, an acute porphyria-like state
was mimicked by the addition of the iron chelator desfer-
rioxamine. Upon addition of thujone, a marked accumu-
lation of protoporphyrin was observed. Bonkovsky et al.
concluded that the tested terpenes, i.e., thujone, are por-
phyrinogenic and hazardous, especially to patients with
underlying defects in hepatic heme synthesis [46].
Animal experiments with wormwood extract
It has to be stressed again that clinical reports of these days
were more or less only descriptive or speculative, as causal
connections between absinthe and thujone and the
above-mentioned symptoms could never reliably be
Table 1: Main acute and chronic effects of absinthe reported in 
the 19th century
Acute effects Chronic absinthism
vertigo mania
seizures softening of the brain
nervous debility general paralysis
hallucinatory delirium psychosisPage 6 of 14
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on animals to prove that wormwood was the causing
agent of absinthism, especially the seizures. All these stud-
ies were carried out using so-called "essence d'absinthe"
(pharmaceutical wormwood extracts) or pure etheric oil
of wormwood, however, often only the term "absinthe"
was used for these extracts. Even in current history books
the terms "absinthe" and "essence d'absinthe" are mis-
leadingly used as synonymous [13].
If injected in pure form, wormwood extracts and alcohol
showed distinctly different symptoms (Table 2). These
results were generalized and transferred to humans who
drank high concentrations of alcohol in combination
with low concentrations of wormwood extract. In further
experiments, guinea pigs – among other small animals –
were placed in the presence of wormwood essence, while
the control guinea pig was "shut up with a saucer of pure
alcohol." In contrast to the animal breathing alcohol,
which was reported to have simply become drunk, the
guinea pig inhaling the vapors of wormwood experienced
initial excitement and subsequently seizures [43].
These experiments and deductions of Magnan et al. were
criticized as early as 1869, when The Lancet commented
upon the inadequacy of the evidence produced in order to
prove that absinthism was different in its nature from
chronic alcoholism. The sleeplessness, the tremor, the hal-
lucinations, the paralysis, and even the seizures, were
described to be well-known symptoms of simple alco-
holic excess. The effect of inhalation of concentrated
wormwood fumes was seen as not transferable to the
effect of very small, continuous oral doses [47]. In Great
Britain, the hostility against Magnans experiments led so
far that the Royal Society for the Prevention of Cruelty to
Animals prosecuted three English doctors for assisting
Magnan in 1874 in demonstrating that intravenous injec-
tion of wormwood extracts into a dog induced epilepsy.
The prosecution failed as Magnan had discreetly returned
to France [48].
Further investigations were undertaken to determine the
origin of the fits in wormwood epilepsy by Boyce [49]. For
this purpose, numerous lesions were made both in the
brain and spinal cord of cats, and wormwood adminis-
tered immediately or after a lapse of days or weeks. It was
found that wormwood, acting upon the bulbo-spinal
centers (including the cerebellum) alone, could produce a
series of "clonic fits", differing from the cortical in the
slower rhythm of the contractions. In experiments of Ott
upon rabbits those results were disputed as no "spinal"
but only "cortical convulsions" were determined, which
raises the question if the crude techniques of the 19th cen-
tury were suitable at all to determine the physiological ori-
gin of epilepsy [50].
In the noteworthy work of Ossipow, the problem of dif-
ferent wormwood extracts to achieve epilepsy in animals
was discussed for the first time [51]. The failure of some
researchers to replicate the experiments of Magnan was
explained by misunderstandings between "absinthe",
"essence d'absinthe", and "extrait d'absinthe". Ossipow
stressed that only the "essence d'absinthe" (alcohol-free
wormwood oil) and not the ready-to-drink alcoholic bev-
erage (in France called "extrait d'absinthe") is usable to
trigger seizures in animals.
Further studies were conducted by Cunningham [52] and
Lesieur [53]. The only consistent conclusion that can be
drawn from all these animal experiments is that worm-
wood oil but not absinthe is a potent agent to cause sei-
zures in animals.
Degeneration and absinthism
A further strong argument of the anti-absinthe phalanx
was grounded on the Lamarckian theories of the inherit-
ance of diseases (Jean-Baptiste Lamarck, 1744–1829).
According to these theories, any traits acquired by
absinthe drinkers would be passed on to their children.
The idea of degeneration was also used by Magnan to
explain mental illnesses [54]. It is interesting to note that
this hereditary feature was also ascribed to alcoholism.
Table 2: Comparative table between symptoms of absinthism and alcoholism according to animal experiments of Amory (1868) [38].
Absinthism (Injection of pure wormwood extract (0.8–4.5 g) 
into the stomach of different animals)
Alcoholism (Injection of alcohol (0.8–5 g) into the stomach of 
different animals)
Animal perfectly well for fifteen minutes, at the least after the ingestion; 
with the exception of a few muscular twichings and a slight uneasiness.
In a very few minutes symptoms of inebriation resulting in torpor.
Musuclar agitation, commencing in the anterior portion of the body. Paralysis, commencing in posterior extremities, and then extending to 
the anterior.
No paralysis. Paralysis of both posterior and anterior extremities in succession.
Epileptiform convulsions and rigidity, resulting in a rapid death. No convulsions. Stupor, coma, resolution and a gradual death.
No apparent lesion, except, perhaps a slight cerebral congestion, 
showing the cause of death to be intoxication of the poison.
Lesions of the brain and of the alimentary canal; gastritis and enteritis 
might have supervened, had the animals lived long enough for their 
developmentPage 7 of 14
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larger proportion of the children of alcoholics were more
"idiotic, epileptic, neurotic, alcoholic, degenerate and
deformed" than the children of healthy parentage, and
total abstinence was postulated [55].
The condition of absinthism was introduced into late 19th
century medicine together with the first emerging descrip-
tions of alcoholism [37]. Intriguingly, this fact could hold
the key for the solution of the debate about whether
absinthism was a clinical pattern of its own and how it
should be distinguished from chronic alcoholism. As
mentioned previously, due to the low solubility of etheric
oils, absinthe usually contains high concentrations of eth-
anol, which means that there was no ingestion of thujone
without ingestion of remarkably high quantities of etha-
nol.
Recently, in an editorial, Strang et al. raised the question
of "absinthe: what's your poison?" [56]. To us, however,
the question is really what happened to the symptoms of
absinthism after its prohibition. Did this mysterious syn-
drome disappear abruptly or did these symptoms simply
continue to exist among chronic alcohol abusers under
the name of alcoholism, which seems to be more toler-
ated by society? Finally, as with so many facets of the
green fairy, this issue remains controversial and perhaps
will never be solved.
Modern studies about pharmacology and 
toxicology of thujone
In the 20th century, as a consequence of the description of
the bicyclic monoterpene thujone as the main component
of wormwood oil, the main focus of scientific studies was
changed from the research of wormwood extract to iso-
lated thujone. It must be stressed, however, that besides
the β-thujone chemotype of the wormwood plant further
chemotypes were described, which contain cis-chrysan-
thenylacetat, cis-chrysanthenol, cis-expoxyocimene, sabi-
nylacetate or bornylacetate as principal component [57-
63]. In the west alpine area above 1000 m the cis-epoxyo-
cimen type is predominat, while the β-thujone type rather
exists in the lower zones [60]. In wormwood oil from the
Tuscany [64] or the Pyrenees [58] neither α- nor β-thujone
could be detected. These significant differences in compo-
sition of wormwood may also be attributable for the pre-
viously described failure of some researchers to replicate
the animal experiments of Magnan.
The acute and chronic toxicology of thujone were
reviewed in the WHO Food Additives Series 16 [65] and
more recently by the Scientific Committee on Food of the
European Commission [66]. The principal data are sum-
marized in Table 3. The toxicological evaluations led to
the establishment of maximum limits for thujone (35 mg/
l in bitters) by the Codex Alimentarius Commission of the
FAO/WHO [67], which were adopted by many countries
including the European Union [8] and Switzerland [68]
but not the USA, where manufacture and importation of
absinthe is still prohibited [69,70]. It was noted, however,
that in the USA consumption and possession remained
legal, so that travelers returning to the USA with a bottle
or customers buying it from Europe on the internet are
not guilty of any crime, though they could have their bot-
tle confiscated [71].
Until today, only little valid data are available concerning
the effect of α-/β-thujone, especially in regard to the influ-
ence on the central nervous system after absinthe con-
sumption. In comparison to β-thujone, α-thujone is
believed to be 2.3 fold more toxic [72]. A recent study of
Dettling et al. showed that the administration of alcohol
containing a high concentration of thujone (100 mg/l)
had a negative effect on attention performance [73].
When the subjects were under the influence of alcohol or
were administered both alcohol and low thujone concen-
trations (10 mg/l), these effects were not observed. Simi-
larly, it was found that only high concentrations of
Table 3: Summary of data about toxicology of thujone
Toxicity data Reference
oral LD50 in rats 192 mg/kg bw [66]
oral LD50 in rats 500 mg/kg bw [107]
iv LD50 in rabbits 0.031 mg/kg bw [107]
NOEL for convulsions in rats 12.5 mg/kg bw (males) [108]
NOEL for convulsions in rats 5 mg/kg bw (females), 10 mg/kg bw (males) [66]
NOEL for convulsions in rats 5 mg/kg bw [66]
TDI (based on NOEL with safety factor of 500) 10 µg/kg bw/d [66]
Metabolism 2-,4-, and 7-hydroxylation [75,76]
Mechanism of toxicity GABA Type A modulation (α-thujone neurotoxicity, convulsant effects) [72,74,76]
Mechanism of toxicity Porphyrogenicity (determined in cultures of chick embryo liver cells) [46]
Behavioral effects 5-HT3 receptor modulation, but no conclusive evidence for psychotropic actions 
of thujone
[77]Page 8 of 14
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of alcohol.
The interaction of α-thujone with γ-amino butyric acid
(GABA) dependent chloride channels can explain its con-
vulsant effects [72,74-76]. It was determined that α-thu-
jone acts like many naturally occurring and synthetic
convulsive agents (e.g. picrotoxin) by blocking GABA
mediated inhibition. The effect on the brain is excitatory
(analeptic). Anxiogenic and possibly alerting effects of
GABA antagonists were also noted. However, Olsen com-
mented that in absinthe one is balancing the effect of thu-
jone with the intoxicating, disinhibitory, and depressant
effects of ethanol [74].
Deiml et al. were not addressing the toxicity but instead
were researching the 5-HT3 receptor as a potential site of
psychotropic actions of α-thujone. In homomeric recep-
tors, α-thujone enhanced the inherent channel-blocking
potency of the natural ligand, 5-HT. In heteromeric recep-
tors, α-thujone recruited an additional channel-blocking
component of the agonist. The authors could, therefore,
prove a reduction of the 5-HT3 receptor activity, but it
stayed open if this inhibitory action on serotonergic
responses contributes to behavioral effects of thujone
[77].
Interestingly, the activation of human bitter taste recep-
tors by α-thujone was recently proven by Behrens et al.
and it was found that the receptor is sufficiently sensitive
to serve as protection against the ingestion of toxic
amounts of this substance [78]. However, it is questiona-
ble if these findings can be transferred to the ingestion of
thujone in alcoholic beverages. Possible receptor interac-
tions between thujone and ethanol as well as differences
between sober and inebriated persons must be taken into
account.
The sometimes observed porphyrinogenic effect of thu-
jone and other terpenoids is explained with the pathway
of metabolization by the hepatic cytochrome P-450 sys-
tem [46,76,79]. Under the presumption of relatively high
thujone concentrations of 260 mg/l, Bonkovsky et al.
speculated that if there is an appreciable hepatic first-pass
extraction and if the rate of hepatic metabolism is not
unusually rapid, the concentrations in the livers of
absinthe drinkers could have been in the 20–200 µM
range. Such concentrations would be sufficient to produce
porphyric crises in patients with underlying defects in
hepatic heme synthesis. An additional effect of ethanol,
perhaps acting synergistically, was also anticipated, since
ethanol and other short-chain alcohols found in alcoholic
beverages are porphyrogenic [46].
Intoxication due to wormwood or thujone rarely occurs,
either due to a misconceived belief in folk remedies or
simple ignorance [80]. In 1862, Smith described a case of
ingestion of about 14 ml of oil of wormwood by a male
adult. The patient was insensible, convulsed, the jaw
clenched, and foaming at the mouth; tendency to vomit
was also present [81]. To our knowledge, there is only one
recent clinical case report by Weisbord et al. from the U.S.
dealing with obvious acute thujone intoxication [82]. A
31-year-old male had ingested "herbal oil," which he had
assumed to be the spirit absinthe and had purchased over
the internet from a website that sold essential oils for aro-
matherapy. Several hours later, the patient became listless,
suffered tonic-clonic seizures and finally developed rhab-
domyolysis and then acute renal failure. It is tempting to
speculate that these symptoms were caused by thujone,
however other ingredients of the herbal oil cannot be
excluded as the culprit.
Very few data published only in non peer-reviewed litera-
ture exist about the pharmacology of thujone. Max
pointed out that the typical 2–4 mg of thujone, which
were consumed per drink were far below the level at
which acute pharmacological effects are observed [83].
This is confirmed by Hinkelbein, who states that by the
consumption of absinthe, up to a blood alcohol concen-
tration of 2.5 g/l, approximately 3.5 mg of thujone are
ingested (0.005 mg/kg bodyweight) [84]. In this order of
magnitude, it is highly improbable that central effects can
be caused by thujone.
A pilot drinking study by Kröner et al. resulted in high
blood alcohol concentration, but as expected no thujone
was detected [85]. The probands examined did not show
any central effect caused by the terpenoids besides the
effect of the alcohol. Therefore, the adverse potency of
absinthe can be neglected, if the EU limit is obeyed.
The German federal institute for risk assessment holds the
view that, even if the legal limit of 35 mg/l is significantly
exceeded, the consumer does not ingest health-threaten-
ing amounts of thujone. Because of the high alcoholic
strength it is advised against a continuous and excessive
consumption [86].
Toxicological rehabilitation of absinthe
Until recently, the thujone content of pre-ban absinthe
was largely unknown and was calculated in 1992 by
Arnold [20] to be as high as 260 mg/l (a value very often
cited in the newer literature, e.g. Refs.
[10,16,46,56,87,88]). The value of 260 mg/l was deter-
mined on the basis that 100 l of absinthe employed 2.5 kg
of dried Artemisia absinthium (1.5% oil, of which 67% is
thujone; corresponding to 251 mg/l of thujone in the
final product) and 1 kg of dried Artemisia pontica for col-Page 9 of 14
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ing to 9 mg/l of thujone in the final product) [20]. Max
independently calculated a similar concentration [83].
These calculations assumed that the total amount of thu-
jone would be recovered in the final product. The follow-
ing three points were given by Arnold to support his
calculation of relatively high concentrations. First, by add-
ing water to the first decoction before heating, a type of
"steam-distillation" was achieved wherein the amount of
any constituent distilled over depends on both its vapor
pressure and molecular weight. In this way the effect of a
low vapor pressure for a particular compound may be
counteracted to some extent by its high molecular weight
relative to that of water. Second, the distillation head of
the industrial apparatus was simple and little attempt was
made to restrict carry-over by aerosol entrainment. And
third, the purpose of the secondary extraction at moderate
temperature was twofold, to achieve a green coloration
and to add additional flavor [20].
However, it cannot be totally disregarded that during dis-
tillation a discrimination of thujone occurs. Historic rec-
ipe books prescribed the removal of the heads and tailings
[26-28]. Duplais, for example, indicates that after macera-
tion in 16 l of alcohol (85%vol) and addition of 15 l of
water, only 15 l of product are withdrawn. 1 l of alcohol
is discarded in the process [30]. In a non peer-reviewed
magazine article, Turner described first experiments con-
ducted by T. Breaux on a French distillery built in 1834.
After distillation in a historic still built for absinthe, the
thujone originally present in the macerate was not recov-
ered in the distillate [71]. The thujone content of absinthe
can then only be caused by the second coloration step,
which would lead to a concentration of 9 mg/l according
to Arnold's calculation.
Baker reports another calculation that resulted in thujone
concentrations of 60–90 mg/l [10]. Wilson [89] estimated
in 1936 that absinthe made from essences contained 1.8
to 45 mg/l, and absinthe made with wormwood con-
tained 2 to 34 mg/l of thujone.
Hutton pointed out that the thujone content of pre-ban
absinthes could have been overestimated because of the
insufficient analytical methods that were available at the
time [88]. Historically applied methods for the determi-
nation of levels of thujone in absinthe were based upon
iodometric titration [90] or color reactions [91]; these
sometimes provided only detection limits as high as 20
mg/l and were therefore unfit for the detection of small
quantities. At the beginning of the 19th century, the most
modern methods were based upon the reaction of thu-
jone with sodium nitroprusside, sodium hydroxide and
acetic acid and provided a limit of detection of 5 mg/l
[92]. However, this color reaction was highly unspecific
and therefore other essential oils, aldehydes and ketones
led to a similar reaction to thujone. Even by improved
sample preparation, it was not possible to avoid these
interferences. A positive reaction in the case of thujone
analysis could not automatically be interpreted in such a
way as to prove that the spirit in question was made with
wormwood. However, a negative result was regarded as
proof of the absence of wormwood oil [93].
The sensitive and selective determination of thujone in
spirits was only possible by using modern chromato-
graphic methods. The first gas chromatographic method
with a flame ionization detector for the determination of
thujone in alcoholic beverages was developed by Mérat et
al. in 1976 [94]. In a recent study of our working group
[95] absinthes produced according to historic recipes did
only contain relatively low concentrations of thujone
(mean: 1.3 ± 1.6 mg/l, range: 0–4.3 mg/l), which is 50–
100 times below the NOEL (No observed effects level) of
thujone for convulsions determined in animal experi-
ments. A vintage absinthe from Tarragona (1930) showed
a relatively low thujone concentration of 1.3 mg/l. Swiss
Val-de-Travers absinthes from traditional small distilleries
contained 9.4 and 1.7 mg/l of thujone. Krumm et al. ver-
ified our results by their production of absinthes after
authentic French recipes. All manufactured products had
thujone concentrations below 1.5 mg/l [96]. Hutton
found 6 mg/l of thujone in a Pernod absinthe from 1900
[88]. In a non peer-reviewed magazine article, Ashcraft
reports tests on pre-ban absinthes conducted by T. Breaux,
who found thujone amounts around 5 mg/l [97]. Schaefer
et al. found such low thujone concentrations (<0.01 mg/
l) in a legal French absinthe dating from 1904 that the
authors even proposed the "toxicological rehabilitation"
of absinthe [98]. In a current study of the neuropsychiatric
toxicity of absinthe by Luauté et al. it was concluded that
recent toxicological studies do not prove, any more than
in Magnan's time, that the beverage itself was epilep-
togenic [99]. The toxicity of pre-ban absinthes, as that of
modern ones, was found to be essentially due to their
alcohol content.
The theory of a gross overestimation of the thujone con-
tent was, therefore, verified by six independent studies
[88,95-99]. The discrepancy between the experimental
findings of pre-ban absinthes (low thujone concentra-
tions) and the calculations of Arnold and Max (high thu-
jone concentrations) [20,83] could not be resolved so far.
Further research is needed to study the behavior of thu-
jone during distillation. Considerable differences to the
composition of the distillate may result between batch-
wise distillation of diluted alcohol and fractional distilla-
tion of an undiluted macerate.Page 10 of 14
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toric absinthes had such high thujone contents to cause
toxic effects. On the contrary, the analyzed historic prod-
ucts appear to have complied with today's maximum lim-
its derived to exclude toxic or other unwanted effects. The
feared return of absinthism, proclaimed e.g. by Hein et al.
[100], Holstege et al. [44] or Müller [101] is therefore
exaggerated. The effects of the recent types of absinthe are
predominantly caused by the naturally high alcoholic
strength (>50%vol), although it is possible to reach effec-
tive thujone blood levels, if illegally produced and distrib-
uted absinthe is ingested.
Present impact of absinthe due to change of 
policy in the European Union
The policy change in the European Union was primarily
based on the fact that absinthe was never prohibited in
some European countries including United Kingdom and
Spain. Under regard of the toxicological studies given
above, the prohibition in other European countries was
seen as a trade barrier, so that a harmonization of the
European law was enacted [8]. Even if a renewal of absin-
thism can be ruled out, the recent re-emergence of
absinthe led to some new problems.
In a recent study it was noted that thujone concentrations
of more than 10 mg/l were found in 22% of commercial
samples [102]. Some of today's commercial samples
appear to have higher thujone concentrations than pre-
ban absinthes. This may be due to the questionable ten-
dency of some absinthe manufacturers and suppliers to
advertise the thujone content and supposed psychoactive
or aphrodisiac properties of their products on their web-
sites. The ancient theories of Magnan et al. are used as a
targeted marketing strategy to bring absinthe into the
sphere of a legal drug-of-abuse.
Baker alluded some of the anecdotal reports on the power
of absinthe, which are detailed in a number of internet
forums, to a mere placebo effect, especially since the
brand in question contained virtually no wormwood at all
[10]. A placebo effect is also a possible interpretation for
the "vaunted aphrodisiac powers" of absinthe that were
advertised in a 1971 Playboy feature on absinthe by Zol-
otow [103]. We found no scientific evidence supporting
the conclusion from the article that "absinthe is one of the
best and safest aphrodisiacs ever invented by the mind of
man". However, the aphrodisiac effects are nowadays
even promised on some absinthe bottle labels.
In addition, slogans such as "contains the maximum
allowed thujone concentration of 35 mg/l" should be crit-
ically judged by the appropriate authorities. Some so-
called absinthe essences (with high thujone contents of
750 mg/l) are even sold on the internet as a possible
means for customers to "regulate the thujone content"
themselves, so that "it is no problem anymore to step
behind the 35-mg border." Absinthe is also often mislead-
ingly advertised as having a cannabis-like effect. This is
based on a hypothesis – again – from Magnan that
absinthe acts in the same way as hashish [43]. The
hypothesis was renewed in 1975 by relatively far-fetched
findings stating that, because of structural similarities
between thujone and tetrahydrocannabinol (THC), both
substances might activate the same receptor in the central
nervous system [104]; this could not be proven in later
experiments by Meschler and Howlett [87]. The THC-
absinthe connection may serve as an archetype of how
conjectural scientific evidence can enter our modern cul-
ture. A search on Google for "absinthe and THC" pro-
duces approximately 36,400 hits mostly of shopping sites,
which advertise absinthe for psychoactive effects. In one
case, the declaration "cannabis-like effect" was even found
on a bottle label.
In closing it should not remain unmentioned that some
high-quality distilleries have re-created absinthes accord-
ing to pre-ban recipes [97]. Hopefully, after the recent de-
restriction of absinthe in Switzerland, absinthe's country
of origin, further high-grade products may show up on the
market. Switzerland also proposed to introduce protected
geographic denominations of origin and protected geo-
graphic indications on the labeling of absinthe, as well as
the ban of artificial food dyes.
Conclusion
From this critical review of the literature, it is concluded
that chronic abuse of absinthe did not cause any distinct
syndrome. The so-called absinthism cannot exactly be dis-
tinguished from chronic alcoholism. The literature gives
proof that the thujone concentrations of pre-ban
absinthes were not able to cause such toxic effects (e.g. sei-
zures) that were found in animal experiments with pure
wormwood extracts. However, much of the literature is
focused on thujone as the potentially toxic component of
absinthe. The possibility remains that other constitutents
found within wormwood or other ingredients of absinthe
may cause potential health problems. The paucity of good
scientific studies about absinthe, especially in the realm of
chronic human consumption and long term effects of thu-
jone-containing beverages must again be pointed out.
Based on the current available evidence, commercially
manufactured absinthe appears to not cause detrimental
health effects other than those encountered in common
alcoholism. The exceptionally high alcoholic strength of
absinthe (>50%vol) alone may lead to major health and
social problems, but is not unique to this spirit. However,
misleading advertisements of aphrodisiac or psychotropic
effects of absinthe try to re-establish absinthe's formerPage 11 of 14
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trolled trade of potentially unsafe herbal products such as
absinthe essences that are readily available over the inter-
net.
On absinthe, Marie Corelli once said: "Let me be mad,
mad with the madness of absinthe, the wildest, most lux-
urious madness in the world" [105]. After having been
banned from most European countries for almost a cen-
tury, the emerald green, mysterious drink has returned to
the market, resuming all the myths and legends of former
years. After the green fairy had inspired the artistic and lit-
erary set of the belle époque and at the same time suppos-
edly poisoned numerous people, the impact that absinthe
will exert on modern society remains unclear.
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